← Back to Clinical Trials
Recruiting NCT07323433

NCT07323433 Efficacy of a Chitosan Dressing in Pulpotomy of Immature Permanent Teeth

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07323433
Status Recruiting
Phase
Sponsor Minia University
Condition Caries,Dental
Study Type INTERVENTIONAL
Enrollment 26 participants
Start Date 2025-08-25
Primary Completion 2026-08-20

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Chitosan Dressing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 26 participants in total. It began in 2025-08-25 with a primary completion date of 2026-08-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Immature permanent teeth, also known as young permanent teeth, are used to describe teeth with incomplete root formation. Immature permanent teeth are prone to caries and trauma which can cause exposure and degeneration of pulp. Pulp degeneration stops root formation, leaving teeth with open apex. It is vital to preserve the pulp vitality otherwise the incompletion of root might result in the fragility of teeth. Pulpotomy is one of the most widely used methods in preserving vital pulp in teeth, which is of great significance in achieving continue root formation in immature permanent teeth suffering from dental caries or trauma. Pulpotomy is recommended by the American Association of Pediatric Dentistry for the management of pulp exposure in immature permanent teeth to achieve apexogenesis (continued root formation and closure of apex). In this procedure, coronal pulp tissue is removed in order to eliminate the infected or contaminated pulp and to reach the healthy vital pulp followed by coverage with biocompatible material.

Eligibility Criteria

Inclusion Criteria: * Patients with immature maxillary anterior teeth. * Patients with caries or traumatic exposed teeth . * Patients should be free from any systemic disease that may affect normal healing and predictable outcome class I ASA . * Patients who will agree to the consent and will commit to follow-up period. Exclusion Criteria: * Patients with mature roots. * Patients with any systemic disease that may affect normal healing. * Patients with signs of periapical inflammation. * Patients who could/would not participate in a 1-year follow-up. * Teeth with periodontal involvement. * Teeth with vertical root fractures. * Non- restorable teeth. * cases with previously initiated endodontic treatment.

Contact & Investigator

Central Contact

Salsabil Mohammed Naguib, MSc

✉ salsabilnaguib@gmail.com

📞 +201026598006

Principal Investigator

Lamiaa Ahmed Ebrahem, Professor

STUDY CHAIR

Department of endodontics Dean of Faculty of Dentistry Fayoum University

Frequently Asked Questions

Who can join the NCT07323433 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 15 Years, studying Caries,Dental. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07323433 currently recruiting?

Yes, NCT07323433 is actively recruiting participants. Contact the research team at salsabilnaguib@gmail.com for enrollment information.

Where is the NCT07323433 trial being conducted?

This trial is being conducted at Minya, Egypt.

Who is sponsoring the NCT07323433 clinical trial?

NCT07323433 is sponsored by Minia University. The principal investigator is Lamiaa Ahmed Ebrahem, Professor at Department of endodontics Dean of Faculty of Dentistry Fayoum University. The trial plans to enroll 26 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology